BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 31402496)

  • 21. TCR-independent CD30 signaling selectively induces IL-13 production via a TNF receptor-associated factor/p38 mitogen-activated protein kinase-dependent mechanism.
    Harlin H; Podack E; Boothby M; Alegre ML
    J Immunol; 2002 Sep; 169(5):2451-9. PubMed ID: 12193714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of T cells by mTOR: the known knowns and the known unknowns.
    Pollizzi KN; Powell JD
    Trends Immunol; 2015 Jan; 36(1):13-20. PubMed ID: 25522665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vav2 activates c-fos serum response element and CD69 expression but negatively regulates nuclear factor of activated T cells and interleukin-2 gene activation in T lymphocyte.
    Tartare-Deckert S; Monthouel MN; Charvet C; Foucault I; Van Obberghen E; Bernard A; Altman A; Deckert M
    J Biol Chem; 2001 Jun; 276(24):20849-57. PubMed ID: 11262396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Nck-Pak1 signaling module is required for T-cell receptor-mediated activation of NFAT, but not of JNK.
    Yablonski D; Kane LP; Qian D; Weiss A
    EMBO J; 1998 Oct; 17(19):5647-57. PubMed ID: 9755165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. mTOR signaling and metabolic regulation of T cells: new potential therapeutic targets in autoimmune diseases.
    Pierdominici M; Vacirca D; Delunardo F; Ortona E
    Curr Pharm Des; 2011 Dec; 17(35):3888-97. PubMed ID: 21933144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapamycin-sensitive signals control TCR/CD28-driven Ifng, Il4 and Foxp3 transcription and promoter region methylation.
    Tomasoni R; Basso V; Pilipow K; Sitia G; Saccani S; Agresti A; Mietton F; Natoli G; Colombetti S; Mondino A
    Eur J Immunol; 2011 Jul; 41(7):2086-96. PubMed ID: 21480212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The FcR gamma subunit and Syk kinase replace the CD3 zeta-chain and ZAP-70 kinase in the TCR signaling complex of human effector CD4 T cells.
    Krishnan S; Warke VG; Nambiar MP; Tsokos GC; Farber DL
    J Immunol; 2003 Apr; 170(8):4189-95. PubMed ID: 12682251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TRAIL-receptor costimulation inhibits proximal TCR signaling and suppresses human T cell activation and proliferation.
    Lehnert C; Weiswange M; Jeremias I; Bayer C; Grunert M; Debatin KM; Strauss G
    J Immunol; 2014 Oct; 193(8):4021-31. PubMed ID: 25217163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of IFN regulatory factor 4 expression in human T cell leukemia virus-I-transformed T cells.
    Sharma S; Grandvaux N; Mamane Y; Genin P; Azimi N; Waldmann T; Hiscott J
    J Immunol; 2002 Sep; 169(6):3120-30. PubMed ID: 12218129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged TCR/CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycin.
    Colombetti S; Basso V; Mueller DL; Mondino A
    J Immunol; 2006 Mar; 176(5):2730-8. PubMed ID: 16493028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bidirectional regulation of nuclear factor-κB and mammalian target of rapamycin signaling functionally links Bnip3 gene repression and cell survival of ventricular myocytes.
    Dhingra R; Gang H; Wang Y; Biala AK; Aviv Y; Margulets V; Tee A; Kirshenbaum LA
    Circ Heart Fail; 2013 Mar; 6(2):335-43. PubMed ID: 23395931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lck is required for activation-induced T cell death after TCR ligation with partial agonists.
    Yu XZ; Levin SD; Madrenas J; Anasetti C
    J Immunol; 2004 Feb; 172(3):1437-43. PubMed ID: 14734719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanistic Target of Rapamycin Complex 1/S6 Kinase 1 Signals Influence T Cell Activation Independently of Ribosomal Protein S6 Phosphorylation.
    Salmond RJ; Brownlie RJ; Meyuhas O; Zamoyska R
    J Immunol; 2015 Nov; 195(10):4615-22. PubMed ID: 26453749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The potency of TCR signaling differentially regulates NFATc/p activity and early IL-4 transcription in naive CD4+ T cells.
    Brogdon JL; Leitenberg D; Bottomly K
    J Immunol; 2002 Apr; 168(8):3825-32. PubMed ID: 11937535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TNFAIP3 promotes survival of CD4 T cells by restricting MTOR and promoting autophagy.
    Matsuzawa Y; Oshima S; Takahara M; Maeyashiki C; Nemoto Y; Kobayashi M; Nibe Y; Nozaki K; Nagaishi T; Okamoto R; Tsuchiya K; Nakamura T; Ma A; Watanabe M
    Autophagy; 2015; 11(7):1052-62. PubMed ID: 26043155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human regulatory T cells rapidly suppress T cell receptor-induced Ca(2+), NF-κB, and NFAT signaling in conventional T cells.
    Schmidt A; Oberle N; Weiss EM; Vobis D; Frischbutter S; Baumgrass R; Falk CS; Haag M; Brügger B; Lin H; Mayr GW; Reichardt P; Gunzer M; Suri-Payer E; Krammer PH
    Sci Signal; 2011 Dec; 4(204):ra90. PubMed ID: 22375050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-12 Influence mTOR to Modulate CD8
    Wang H; Li J; Han Q; Yang F; Xiao Y; Xiao M; Xu Y; Su L; Cui N; Liu D
    Int J Med Sci; 2017; 14(10):977-983. PubMed ID: 28924369
    [No Abstract]   [Full Text] [Related]  

  • 38. Active protein kinase B regulates TCR responsiveness by modulating cytoplasmic-nuclear localization of NFAT and NF-kappa B proteins.
    Patra AK; Na SY; Bommhardt U
    J Immunol; 2004 Apr; 172(8):4812-20. PubMed ID: 15067058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. mTOR, metabolism, and the regulation of T-cell differentiation and function.
    Waickman AT; Powell JD
    Immunol Rev; 2012 Sep; 249(1):43-58. PubMed ID: 22889214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Interleukin-2-mTORc1 Kinase Axis Defines the Signaling, Differentiation, and Metabolism of T Helper 1 and Follicular B Helper T Cells.
    Ray JP; Staron MM; Shyer JA; Ho PC; Marshall HD; Gray SM; Laidlaw BJ; Araki K; Ahmed R; Kaech SM; Craft J
    Immunity; 2015 Oct; 43(4):690-702. PubMed ID: 26410627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.